Projects per year
Personal profile
Personal profile
Dr. Ganguly is a board-certified hematologist specializing in the clinical care and research of hematological malignancies, cellular therapeutics, and bone marrow transplantation. Dr. Ganguly was a A. Drue Jennings endowed professor of medical oncology at the University of Kansas Cancer Center in Westwood, Kansas where he was also the Deputy Director of the Division of Hematological Malignancies and Cellular Therapeutics, the Associate Director of Blood and Marrow Transplantation Program, and the Director of Lymphoma and Myeloma Program.
Dr. Ganguly received his undergraduate degree from Calcutta Medical College and his medical degree from the Department of Internal Medicine, Post Graduate, Institute of Medical Education and Research in India. Additionally, he completed his residency in internal medicine and fellowship in hematology at Baylor College of Medicine and concluded another fellowship in bone marrow transplantation at Baylor College of Medicine, Center for Cell and Gene Therapy.
External positions
Professor of Clinical Medicine, Weill Cornell Medical College
May 1 2022 → …
Research Area Keywords
- Cancer
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma
Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
1/28/25 → …
Project: Clinical Trial
-
A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia
Shah, S. (PI), Ganguly, S. (Key Personnel), Mai, H. P. (Key Personnel) & Pingali, S. R. (Key Personnel)
10/25/24 → …
Project: Clinical Trial
-
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Shah, S. (Key Personnel) & Yi, Q. (Key Personnel)
7/29/24 → …
Project: Clinical Trial
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Ganguly, S. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Shah, S. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma (MM)
Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
3/21/24 → …
Project: Clinical Trial
-
Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
Mercadal, S., Ahn, K. W., Allbee-Johnson, M., Ganguly, S., Geethakumari, P. R., Hong, S., Malone, A., Murthy, H., Pawarode, A., Sica, A. R., Solh, M., Ustun, C., Shadman, M., Sauter, C. S., Hamadani, M., Herrera, A. F. & Lee, C. J., Jan 2025, In: Haematologica. 110, 1, p. 218-221 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers
Qian, J., Wang, Q., Xiao, L., Xiong, W., Xian, M., Su, P., Yang, M., Zhang, C., Li, Y., Zhong, L., Ganguly, S., Zu, Y. & Yi, Q., Jan 24 2024, In: Journal for immunotherapy of cancer. 12, 1, e008145.Research output: Contribution to journal › Article › peer-review
Open Access -
Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study
Jain, T., Estrada-Merly, N., Salas, M. Q., Kim, S., DeVos, J., Chen, M., Fang, X., Kumar, R., Andrade-Campos, M., Elmariah, H., Agrawal, V., Aljurf, M., Bacher, U., Badar, T., Badawy, S. M., Ballen, K., Beitinjaneh, A., Bhatt, V. R., Bredeson, C. & De Filipp, Z. & 44 others, , Aug 27 2024, In: Blood Advances. 8, 16, p. 4281-4293 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Editor's Note: Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
Fiskus, W., Rao, R., Balusu, R., Ganguly, S., Tao, J., Sotomayor, E., Mudunuru, U., Smith, J. E., Hembruff, S. L., Atadja, P., Marquez, V. E. & Bhalla, K., May 1 2024, In: Clinical Cancer Research. 30, 9, p. 1994 1 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study
Kahn, J., Brazauskas, R., Bo-Subait, S., Buchbinder, D., Hamilton, B. K., Schoemans, H., Abraham, A. A., Agrawal, V., Auletta, J. J., Badawy, S. M., Beitinjaneh, A., Bhatt, N. S., Broglie, L., Diaz Perez, M. A., Farhadfar, N., Freytes, C. O., Gale, R. P., Ganguly, S., Hayashi, R. J. & Hematti, P. & 20 others, , Oct 2024, In: The Lancet Child and Adolescent Health. 8, 10, p. 740-750 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations